Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation
    Journal Article

    Kauff, N. D.; Satagopan, J. M.; Robson, M. E.; Scheuer, L.; Hensley, M.; Hudis, C. A.; Ellis, N. A.; Boyd, J.; Borgen, P. I.; Barakat, R. R.; more...
    New England Journal of Medicine (2002)

    Fulltext@MSK | Save
  • Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families
    Journal Article

    Kauff, N. D.; Perez-Segura, P.; Robson, M. E.; Scheuer, L.; Siegel, B.; Schluger, A.; Rapaport, B.; Frank, T. S.; Nafa, K.; Ellis, N. A.; more...
    Journal of Medical Genetics (2002)

    Fulltext@MSK | Save
  • BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90
    Journal Article

    Gorre, M. E.; Ellwood-Yen, K.; Chiosis, G.; Rosen, N.; Sawyers, C. L.
    Blood (2002)

    Fulltext@MSK | Save
  • Development of a purine-scaffold novel class of hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase
    Journal Article

    Chiosis, G.; Lucas, B.; Shtil, A.; Huezo, H.; Rosen, N.
    Bioorganic & Medicinal Chemistry (2002)

    Fulltext@MSK | Save
  • Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2
    Journal Article

    Basso, A. D.; Solit, D. B.; Munster, P. N.; Rosen, N.
    Oncogene (2002)

    Fulltext@MSK | Save
  • Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function
    Journal Article

    Basso, A. D.; Solit, D. B.; Chiosis, G.; Giri, B.; Tsichlis, P.; Rosen, N.
    Journal of Biological Chemistry (2002)

    Fulltext@MSK | Save
  • Norton-Simon hypothesis
    Book Section

    Gilewski, T. A.; Norton, L.
    In Perry, M. C. (Eds.) The Chemotherapy Source Book. 3rd ed (2001)

    Fulltext@MSK | Save
  • Breast Cancer Working Group
    Journal Article

    McCormick, B.; Strom, E.; Craighead, P. S.; Kuske, R.; Hudis, C.; Ley, J.; Margolis, L.; Meyerwitz, B.; Morris, E.; Petrek, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2001)

    Fulltext@MSK | Save
  • Synthesis and evaluation of a library of small molecules that degrade the HER2-tyrosine kinase
    Meeting Abstract

    Chiosis, G.; Lucas, B.; Timaul, M.; Rosen, N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • Modulation of Hsp90 function by ansamycins enhances chemotherapy induced apoptosis in breast cancer cell lines in an RB and schedule dependent manner
    Meeting Abstract

    Munster, P. N.; Basso, A. D.; Solit, D.; Norton, L.; Scher, H.; Rosen, N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save